Comprehensively, our findings suggest that high CXCR2P1 expression may reduce hsa-miR-215-5p levels in tumor tissues through the lncRNA-microRNA regulatory axis, potentially improving the prognosis of gastric cancer patients. This evidence concerns the gene CXCR2P1 and gastric cancer.